TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The ...
For chemical manufacturers, these "oops" moments aren't just embarrassing—they're expensive. When you're managing ...
Veeva Systems (NYSE:VEEV) serves the life sciences software sector with products designed for pharmaceutical and biotechnology organizations. Recent developments highlight a stronger shift toward its ...
Veeva Systems (VEEV) reports Q4 earnings tonight with Wall Street expecting revenue of ~$808.5M and EPS of $1.94. The stock trades at $186.90, down 16.28% YTD, with 115 Vault CRM customers live. We’ll ...
Veeva Systems reported fourth-quarter revenue of $836 million, up 16% year-over-year. The revenue total beat a Street consensus estimate of $810.6 million, according to data from Benzinga Pro. The ...
Veeva Sys (NYSE:VEEV) is gearing up to announce its quarterly earnings on Wednesday, 2026-03-04. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...
With broad industry success and the availability of Veeva AI, Vault CRM is the leader in agentic CRM for life sciences PLEASANTON, Calif., March 3, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) ...
If you look at what we're doing in Healthcare and Life Sciences specifically, we are all in. Our boats have been burned. It was never actually in doubt that Salesforce was indeed “all in” on cracking ...
The latest announcement is out from Veeva Systems ( (VEEV)). On January 5, 2026, Veeva Systems announced that its board had authorized the company’s first-ever share repurchase program, allowing the ...
Veeva Systems Inc. (NYSE:VEEV) is one of the best healthcare AI stocks to buy now. On December 15, Stifel reiterated a Buy rating on Veeva Systems Inc. (NYSE:VEEV), even as some big pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results